Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQY93
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,965
Award facts
- Contract value 100% obligated
- $24,964.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $25K to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on June 5, 2025, with completion expected by June 6, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement from the vendor's corporate office located in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare settings for symptom management across various medical conditions.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of competitively-awarded contracts with the DLA for medical supply chain support, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities to support military healthcare programs globally. The company's presence as a prime vendor on this comprehensive contract vehicle demonstrates its capability to fulfill federal medical procurement requirements efficiently across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQY93?
SPE2DB25FQY93 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 5, 2025.
How much is contract SPE2DB25FQY93 worth?
The government has obligated $24,965 on SPE2DB25FQY93.
Is contract SPE2DB25FQY93 an order under another contract?
Yes. SPE2DB25FQY93 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQY93 competed?
The extent of competition for SPE2DB25FQY93 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award